These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 15110093)

  • 1. Targeted hepatic overexpression of human IRS-1: postnatal effects in the developing mouse.
    Giannone PJ; Abu Dayyeh BK; Bienieki TC; Wands JR; Gruppuso PA
    Biochim Biophys Acta; 2004 May; 1672(2):112-9. PubMed ID: 15110093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological effects of human insulin receptor substrate-1 overexpression in hepatocytes.
    Tanaka S; Mohr L; Schmidt EV; Sugimachi K; Wands JR
    Hepatology; 1997 Sep; 26(3):598-604. PubMed ID: 9303488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin signaling during perinatal liver development in the rat.
    Anand P; Boylan JM; Ou Y; Gruppuso PA
    Am J Physiol Endocrinol Metab; 2002 Oct; 283(4):E844-52. PubMed ID: 12217903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspartyl-(asparaginyl)-beta-hydroxylase regulates hepatocellular carcinoma invasiveness.
    de la Monte SM; Tamaki S; Cantarini MC; Ince N; Wiedmann M; Carter JJ; Lahousse SA; Califano S; Maeda T; Ueno T; D'Errico A; Trevisani F; Wands JR
    J Hepatol; 2006 May; 44(5):971-83. PubMed ID: 16564107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin receptor substrate 3 (IRS-3) and IRS-4 impair IRS-1- and IRS-2-mediated signaling.
    Tsuruzoe K; Emkey R; Kriauciunas KM; Ueki K; Kahn CR
    Mol Cell Biol; 2001 Jan; 21(1):26-38. PubMed ID: 11113178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postnatal growth responses to insulin-like growth factor I in insulin receptor substrate-1-deficient mice.
    Pete G; Fuller CR; Oldham JM; Smith DR; D'Ercole AJ; Kahn CR; Lund PK
    Endocrinology; 1999 Dec; 140(12):5478-87. PubMed ID: 10579310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmental switch from prolonged insulin action to increased insulin sensitivity in protein tyrosine phosphatase 1B-deficient hepatocytes.
    Gonzalez-Rodriguez A; Clampit JE; Escribano O; Benito M; Rondinone CM; Valverde AM
    Endocrinology; 2007 Feb; 148(2):594-608. PubMed ID: 17068137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin receptor substrate-4 signaling in quiescent rat hepatocytes and in regenerating rat liver.
    Escribano O; Fernández-Moreno MD; Zueco JA; Menor C; Fueyo J; Ropero RM; Diaz-Laviada I; Román ID; Guijarro LG
    Hepatology; 2003 Jun; 37(6):1461-9. PubMed ID: 12774026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of insulin receptor substrates-1 and -2 (IRS-1 and IRS-2) and phosphatidylinositol 3-kinase isoforms in liver and muscle of the obese diabetic (ob/ob) mouse.
    Kerouz NJ; Hörsch D; Pons S; Kahn CR
    J Clin Invest; 1997 Dec; 100(12):3164-72. PubMed ID: 9399964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential phosphorylation of insulin receptor substrate-2 by glycogen synthase kinase-3 and c-Jun NH2-terminal kinase plays a role in hepatic insulin signaling.
    Sharfi H; Eldar-Finkelman H
    Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E307-15. PubMed ID: 18029441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Essential role of insulin-like growth factor I receptor in insulin-induced fetal brown adipocyte differentiation.
    Mur C; Arribas M; Benito M; Valverde AM
    Endocrinology; 2003 Feb; 144(2):581-93. PubMed ID: 12538620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IRS-2 mediates the antiapoptotic effect of insulin in neonatal hepatocytes.
    Valverde AM; Fabregat I; Burks DJ; White MF; Benito M
    Hepatology; 2004 Dec; 40(6):1285-94. PubMed ID: 15565601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of Gab1 in the liver leads to enhanced glucose tolerance and improved hepatic insulin action.
    Bard-Chapeau EA; Hevener AL; Long S; Zhang EE; Olefsky JM; Feng GS
    Nat Med; 2005 May; 11(5):567-71. PubMed ID: 15821749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ETV6-NTRK3 transformation requires insulin-like growth factor 1 receptor signaling and is associated with constitutive IRS-1 tyrosine phosphorylation.
    Morrison KB; Tognon CE; Garnett MJ; Deal C; Sorensen PH
    Oncogene; 2002 Aug; 21(37):5684-95. PubMed ID: 12173038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of insulin-like growth factor signaling pathways in mammary gland by pure antiestrogen ICI 182,780.
    Chan TW; Pollak M; Huynh H
    Clin Cancer Res; 2001 Aug; 7(8):2545-54. PubMed ID: 11489838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutive over-expression of the insulin receptor substrate-1 causes functional up-regulation of Fas receptor.
    Wiedmann M; Tamaki S; Silberman R; de la Monte SM; Cousens L; Wands JR
    J Hepatol; 2003 Jun; 38(6):803-10. PubMed ID: 12763374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo.
    Lee AV; Jackson JG; Gooch JL; Hilsenbeck SG; Coronado-Heinsohn E; Osborne CK; Yee D
    Mol Endocrinol; 1999 May; 13(5):787-96. PubMed ID: 10319328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin receptor substrate-1 is present in hepatocyte nuclei from intact rats.
    Boylan JM; Gruppuso PA
    Endocrinology; 2002 Nov; 143(11):4178-83. PubMed ID: 12399410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver-specific expression of human insulin-like growth factor binding protein-1 in transgenic mice: repercussions on reproduction, ante- and perinatal mortality and postnatal growth.
    Gay E; Seurin D; Babajko S; Doublier S; Cazillis M; Binoux M
    Endocrinology; 1997 Jul; 138(7):2937-47. PubMed ID: 9202238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progesterone receptor-B regulation of insulin-like growth factor-stimulated cell migration in breast cancer cells via insulin receptor substrate-2.
    Ibrahim YH; Byron SA; Cui X; Lee AV; Yee D
    Mol Cancer Res; 2008 Sep; 6(9):1491-8. PubMed ID: 18819936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.